Treatment of ID8 tumor-bearing mice with AAV vectors expressing 3TSR, CD47 binding peptide, or 3TSR + CD47 binding peptide resulted in a significant reduction in the size of the primary tumor and, in some cases, in the number of secondary lesions. Here, CD47 is linked to neoplasm.